Antigen associated with the neovasculature of tumour metastases
US8263041B2 · kind B2 · utility
9Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 31, 2008 |
| Grant date | Sep 11, 2012 |
| Priority date | — |
| Expiry date | Mar 31, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a binding member that binds the Extra Domain-A (ED-A) isoform of fibronectin for the treatment of tumor metastases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.